Law firms Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business · 1 February 2016 · 1 min read Corporate and M&A Cravath, Swaine & Moore Kirkland & Ellis Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryTrading Places: A&O Shearman energy and infra co-head moves to DLA as Linklaters builds in New York with Paul Weiss hireLaw firmsKate Peacock7 Aug 2026Simpson Thacher opens in Chicago with five-partner hire from KirklandLaw firmsKate Peacock6 Aug 2026The $400bn AstraZeneca mega-merger: which firms could land the mandate?Law firmsEliza Winter5 Aug 2026Slaughters and Freshfields in line for over £25m in fees from Rotork-ABB dealLaw firmsKate Peacock7 Aug 2026Macfarlanes advises founder as easyJet accepts £5.7bn Apollo takeover bidLaw firmsKate Peacock6 Aug 2026Revolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesLaw firmsAnna Huntley9 Jan 2025‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetryLaw firmsAnna Huntley7 Jan 2025Five partners vie to succeed Hoyland as Simmons managing partnerLaw firmsTom Cox7 Jan 2025Former Freshfields senior partner among recipients in New Year Honours ListLaw firmsTom Cox2 Jan 2025